Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed) – Scholarship and Grants Opportunities

    0
    467
    Funding Opportunity ID: 309059
    Opportunity Number: PAR-18-923
    Opportunity Title: Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
    Opportunity Category: Discretionary
    Opportunity Category Explanation:
    Funding Instrument Type: Grant
    Category of Funding Activity: Health
    Category Explanation:
    CFDA Number(s): 93.855
    Eligible Applicants: State governments
    County governments
    City or township governments
    Special district governments
    Independent school districts
    Public and State controlled institutions of higher education
    Native American tribal governments (Federally recognized)
    Public housing authorities/Indian housing authorities
    Native American tribal organizations (other than Federally recognized tribal governments)
    Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
    Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
    Private institutions of higher education
    For profit organizations other than small businesses
    Small businesses
    Others (see text field entitled “Additional Information on Eligibility” for clarification)
    Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
    Agency Code: HHS-NIH11
    Agency Name: Department of Health and Human Services
    National Institutes of Health
    Posted Date: Sep 17, 2018
    Close Date: Jan 14, 2021
    Award Ceiling: $200,000
    Award Floor: $0
    Estimated Total Program Funding:
    Expected Number of Awards:
    Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative studies to identify and understand the immunological responses that mediate protection from Mycobacterium tuberculosis (Mtb) infection or following vaccination with Bacillus Calmette-Gurin (BCG) or investigational vaccines. Studies may focus on any stage of mycobacterial infection and may include HIV-infected or uninfected individuals. Development of novel functional assays to assess host response and inclusion of immune profiling and systems biology approaches are encouraged. This FOA seeks to stimulate innovative research in deciphering immune mechanisms in humans required for protection from Mtb infection or tuberculosis (TB) disease, or induced by TB vaccines that go beyond what have traditionally been investigated in TB.
    Version: 1

    Visit the Official Webpage For More Details on Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)

    LIKE WHAT YOU READ & WOULD LOVE TO BE INFORMED OF NEW OPPORTUNITIES? CLICK TO DOWNLOAD SCHOLARSHIP AND GRANTS ANDROID APP ON GOOGLE PLAY

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here